The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma

American Journal of Ophthalmology

Volumn 134, Issue 4, 2002, Pages 499-512

  Blackwell, Beth ^b   Gaasterland, Douglas ^b   Ederer, Fred ^b   Dally, Leonard G ^b   VanVeldhuisen, Paul ^a   Prum, Bruce E ^b   Cyrlin, Marshall ^b   Katz, L Jay ^b   Weiss, Howard ^b   Lichter, Paul ^b   Wilensky, Jacob ^b  

^a Advanced Glaucoma Intervention Study   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARGON LASER; ARGON LASER TRABECULOPLASTY; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLAUCOMA; HAZARD ASSESSMENT; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE REGRESSION; OPTIC DISK ANOMALY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURGICAL RISK; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME; TYPES OF STUDY; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT;

AGED; COHORT STUDIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TRABECULECTOMY; VISUAL ACUITY; VISUAL FIELDS;

EID: 0036807994     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01659-8     Document Type: Article

References (43)

1. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty in advanced glaucoma patients. Am J Ophthalmol. 134:2002;481-498.
2. Advanced Glaucoma Intervention Study (AGIS) Manual of Operations. 1993;National Technical Information Service: Accession No. PB93-220192, Springfield, VA.
3. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):1. Study design and methods and baseline characteristics of study patients. Control Clin Trials. 15:1994;299-325.
4. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):2. Visual field test scoring and reliability. Ophthalmology. 101:1994;1445-1455.
5. Early Treatment Diabetic Retinopathy Study Research Group . Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics ETDRS Report Number 7 . Ophthalmology. 98:1991;741-756.
6. Lee E.W., Wei L.J., Amato D.A. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. Klein J.P., Goel P.K., Survival analysis State of the art . 1992;237-247 Kluwer Academic, Dordrecht, Netherlands.
7. O'Brien C., Schwartz B., Takamoto T., Wu D.C. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 111:1991;491-500.
8. Popovic V., Sjostrand J. Long-term outcome following trabeculectomy II Visual field survival . Acta Ophthalmol (Copenh). 69:1991;305-309.
9. Holmin C., Storr-Paulsen A. The visual field after trabeculectomy. A follow-up study using computerized perimetry. Acta Ophthalmol. 62:1984;230-234.
10. Chen P.P., Park R.J. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology. 107:2000;1688-1692.
11. Ishida K., Yamamoto T., Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 7:1998;372-377.
12. Martinez-Bello C., Chauhan B.C., Nicolela M.T., McCormick T.A., LeBlanc R.P. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol. 129:2000;302-308.
13. Wilson R., Walker A.M., Dueker D.K., Crick R.P. Risk factors for rate of progression of glaucomatous visual field loss a computer-based analysis . Arch Ophthalmol. 100:1982;737-741.
14. Suzuki Y., Shirato S., Adachi M., Hamada C. Risk factors for the progression of treated primary open-angle glaucoma a multivariate life-table analysis . Graefes Arch Clin Exp Ophthalmol. 237:1999;463-467.
15. Berggren L., Widengard I. Visual impairment of open angle glaucomas at first presentation and after a five to ten year follow-up. Upsala J Med Sci. 97:1992;251-260.
16. Araie M., Sekine M., Suzuki Y., Koseki N. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology. 101:1994;1440-1444.
17. Daugeliene L., Yamamoto T., Kitazawa Y. Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol. 237:1999;105-108.
18. Katz J., Gilbert D., Quigley H.A., Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 104:1997;1017-1025.
19. Kwon Y.H., Kim C.-S., Zimmerman B., Alward W.L.M., Hayreh S.S. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 132:2001;47-56.
20. Rasker M.T.E., van den Enden A., Bakker D., Hoyng P.F.J. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 118:2000;481-488.
21. Schultz J.S., Werner E.B., Krupin T., Bishop K.I., Koelle J. Intraocular pressure and visual field defects after argon laser trabeculoplasty in chronic open-angle glaucoma. Ophthalmology. 94:1987;553-557.
22. Smith S.D., Katz J., Quigley H.A. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 37:1996;1419-1428.
23. Stewart W.C., Kolker A.E., Sharpe E.D., Day D.G., Holmes K.T., Leech J.N., Johnson M., Cantrell J.B. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Opthalmol. 130:2000;274-279.
24. Dallas N.L., Sponsel W.E., Hobley A.J. A comparative evaluation of Timolol Maleate and Pilocarpine in the treatment of chronic open angle glaucoma. Eye. 2:1988;243-249.
25. Mao L.K., Stewart W.C., Shields M.B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 111:1991;51-55.
26. Drance S., Anderson D.R., Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 131:2001;699-708.
27. Diestelhorst M., Khalili M.A., Krieglstein G.K. Trabeculectomy a retrospective follow-up of 700 eyes . Intern Ophthalmol. 22:1999;211-220.
28. Chihara E., Liu X., Dong J., Takashima Y., Akimoto M., Hangai M., Kuriyama S., Tanihara H., Hosoda M., Taukahara S. Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma. Ophthalmologica. 211:1997;66-71.
29. Noureddin B.N., Poinoosawmy D., Fietzke F.W., Hitchings R.A. Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol. 75:1991;493-495.
30. Olivius E., Thorburn W. Prognosis of glaucoma simplex and glaucoma capsulare, A comparative review. Acta Ophthalmol. 56:1978;921-934.
31. Wilson R., Richardson T.M., Hertzmark E., Grant W.M. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol. 17:1985;653-659.
32. Hattenhauer M.G., Johnson D.H., Ing H.H., Herman D.C., Hodge D.O., Yawn B.P., Butterfield L.C., Gray D.T. The probability of blindness from open-angle glaucoma. Ophthalmology. 105:1998;2099-2104.
33. Parc Christine E., Johnson D.H., Oliver J.E., Hattenhauer M.G., Hodge D.O. The long-termm outcome of glaucoma filtering surgery. Am J Ophthalmol. 132:2001;27-35.
34. Molteno A.C.B., Bosma N.J., Kittelson J.M. Otago glaucoma surgery outcome study long-term results of trabeculectomy - 1976 to 1995 . Opthalmology. 106:1999;1742-1750.
35. Hiller R., Sperduto R.D., Ederer F. Emidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 134:1986;916-925.
36. Kahn H.A., Leibowitz H.M., Ganley J.P., Kini M.M., Colton T., Nickerson R.S., Dawber T.R. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 106:1977;33-41.
37. Leske M.C., Chylack L.T. Jr, Wu S.Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol. 109:1991;244-251.
38. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):8. Risk of cataract after trabeculectomy. Arch Ophthalmol. 119:2001;1771-1780.
39. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):6. Effect of cataract on visual field and visual acuity. Arch Ophthalmol. 118:2000;1639-1652.
40. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS):9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol. 132:2001;311-320.
41. Lichter P.R. Variability of expert observers in evaluating the optic disc. Trans Am Soc Ophthalmol. 74:1976;532.
42. Kahn H.A., Leibowitz H., Ganley J.P., Kini M., Colton T., Nickerson R., Dawber T.R. Standardizing diagnostic procedures. Am J Ophthalmol. 79:1975;768-775.
43. Gaasterland D.E., Blackwell B., Dally L.G., Caprioli J., Katz L.J., Ederer F.E., The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS) 10. Variability among academic glaucoma subspecialists in assessing optic disc notching . Trans Am Ophthalmol Soc. 99:2001;177-185.